Bone and Soft Tissue Pathology

Bone and soft tissue pathology provides comprehensive consultative expertise and services relating to disorders in soft tissue and bone. Because of the complexity and difficulty involved in diagnosing bone and soft tissue disorders, as well as the clinical implications of the diagnoses, expert consultation is extremely important in correctly classifying bone and soft tissue tumors. In addition to consultative services, a variety of specialized molecular tests are routinely available.

For information concerning consultation, please call (801) 581-2507. Surgical Pathology consultations can be electronically ordered using test code 2013263 and sent to the below address:

Surgical Pathology Department
Huntsman Cancer Institute
2000 Circle of Hope, RM 1300
Salt Lake City, UT 84112
Phone: (801) 581-2507
Fax: (801) 581-7035

Please include pertinent clinical history, surgical pathology report(s) and complete case materials.
  • Medical Director, Anatomic Pathology and Molecular Oncology
    Dr. Grossmann received a BS in zoology at the College of Idaho and a PhD and MD from the Oregon Health Sciences University, where she studied tyrosine kinase substrate specificity with Brian J. Druker, MD. Dr. Grossmann completed both a residency in anatomic pathology and a research fellowship in molecular medicine at the University of Utah. Her postdoctoral work in the laboratory of Dean Y. Li, MD, PhD, focused on the role of small GTPases in melanoma invasion and metastasis. Most recently, Dr. Grossmann completed a fellowship in molecular genetic pathology at ARUP Laboratories. Her primary subspecialty interests are sarcoma pathology and molecular oncology. Her research interests include mechanisms of tumorgenesis, metastasis, and the development of targeted therapies for cancer treatment.
  • Medical Director, Anatomic Pathology
    Director, Anatomic Pathology Clinical Trials
    Director, Surgical Pathology Fellowship Program
    Dr. Liu is a professor of pathology at the University of Utah School of Medicine. Dr. Liu received her MD from Beijing University of Chinese Medicine and her MS in pathophysiology from Peking Union Medical College. She completed AP/CP residency training at Drexel University College of Medicine, a fellowship in hematology at Drexel University College of Medicine, and an oncologic/surgical fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Liu is an AP/CP and hematopathology-boarded pathologist. Her current research interests include oncologic clinical research.